Pediatric Antipsychotic Utilization Program (Revised)
Summary
Humana has revised its Pediatric Antipsychotic Utilization Program (effective April 15, 2026) establishing stricter prior authorization requirements for all antipsychotic medications in pediatric patients aged <6 years (requires compendia-supported diagnosis) and ≥6 years (standard coverage), plus new restrictions on concurrent antipsychotic use in patients ≥6 years. This policy applies to Florida, South Carolina, Oklahoma, and Virginia Medicaid plans and affects 60+ antipsychotic formulations across typical and atypical classes.
Get alerts when payers change rules like this one
We check Humana and other payers every day and email you when a change matches your specialty and state.